Manning Meredith 4
4 · SOLENO THERAPEUTICS INC · Filed Jan 23, 2025
Insider Transaction Report
Form 4
Manning Meredith
Chief Commercial Officer
Transactions
- Award
Employee stock option (right to buy)
2025-01-21+29,200→ 29,200 totalExercise: $49.17Exp: 2035-01-21→ Common Stock (29,200 underlying) - Award
Common Stock
2025-01-21+13,600→ 53,600 total
Footnotes (3)
- [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on each annual anniversary of December 15, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
- [F2]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F3]1/48th of the shares subject to the option shall vest on February 1, 2025 and 1/48th of the remaining shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.